J Pathol Bacteriol
it is a dual GIP/GLP-1 receptor agonist that activates both GIP and GLP-1 receptors simultaneously
A 2026 Washington University School of Medicine analysis of veterans with type 2 diabetes found that even brief interruptions of GLP-1 treatment -- as little as six months -- were associated with higher risk of heart attack, stroke, and death compared with continuous use
Instead, real transformation requires optimizing the microscopic biological pathways that govern how your muscle cells behave
In many cases, continuous glucose monitoring devices improve accuracy and adherence
doi: 10.3389/fcell.2022.806081 Received 31 October 2021 Accepted 03 February 2022 Published 03 March 2022 Volume 10 - 2022 Edited by Xiongwen Chen, Temple University, United States Reviewed by Qian Xiang, Peking University First Hospital, China Jamal Bouitbir, University of Basel, Switzerland Updates Copyright 2022 Zhang, Qu, Chen, Luo, Chen, Xiao, Ding, Zhao, Lu, Chen and Yu